Company profile: Molecubes
1.1 - Company Overview
Company description
- Provider of preclinical imaging cubes combining SPECT, PET, and CT for small-animal whole-body imaging. Solutions include X-CUBE micro-CT (high-resolution), β-CUBE micro-PET (high sensitivity and resolution), and γ-CUBE SPECT (high-sensitivity, high-resolution, patented technology). Also offers CUBEFLOW software for streamlined imaging workflows and REMI reconstruction engine for simultaneous and batch processing.
Products and services
- β-CUBE: A micro-PET scanner engineered for small animal whole-body imaging, delivering high sensitivity and resolution for detailed preclinical acquisitions
- γ-CUBE: A SPECT imager for whole-body mouse and rat imaging, offering high sensitivity and resolution and featuring patented technology for preclinical use
- X-CUBE: A micro-CT scanner engineered for small animal whole-body imaging, producing high-resolution images for preclinical research
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Molecubes
Gatan
HQ: United States
Website
- Description: Provider of instrumentation and software that enhance and extend electron microscopes, compatible with all brands and spanning the workflow from specimen preparation and manipulation to imaging and analysis. Products include GIF Quantum ER for energy-filtered imaging and EELS, K2 Summit cryo-EM camera, Monarc Pro T for optically coupled TEM, ClearView TEM camera, DigitalMicrograph software, and service plans.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gatan company profile →
NanoCellect Biomedical
HQ: United States
Website
- Description: Provider of microfluidic cell analysis and sorting solutions, including WOLF G2 benchtop cell sorter with two lasers and up to nine colors for gentle bulk or single-cell workflows; VERLO image-guided sorter combining flow cytometry with image analysis for complex samples; N1 single-cell dispenser for 96-/384-well plates; CS1 chiller-stirrer for temperature control; and disposable, sterile microfluidic cartridges without cross-contamination.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NanoCellect Biomedical company profile →
CMA Microdialysis
HQ: Sweden
Website
- Description: Provider of specialized tools for biological research in preclinical settings.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CMA Microdialysis company profile →
PhoreMost
HQ: United Kingdom
Website
- Description: Provider of phenotypic screening and targeted protein degradation solutions, including the SITESEEKER® platform using PROTEINi® libraries to identify novel drug targets and druggable sites in live cells, and GlueSEEKER™ to discover molecular glue degraders. Offers an oncology-focused pipeline of first-in-class targets and E3 ligase-based degraders, and partnering services applying SITESEEKER® across therapeutic areas.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PhoreMost company profile →
BD Biosciences
HQ: United States
Website
- Description: Provider of flow cytometers; research cell analyzers and cell sorters; clinical cell analyzers; single-cell multiomics systems; and automated sample preparation systems for flow cytometry, supporting applications in immunology, cancer research, diagnostics, and clinical research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BD Biosciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Molecubes
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Molecubes
2.2 - Growth funds investing in similar companies to Molecubes
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Molecubes
4.2 - Public trading comparable groups for Molecubes
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →